Compare SDRL & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SDRL | HAE |
|---|---|---|
| Founded | 2005 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.8B |
| IPO Year | 2018 | 1996 |
| Metric | SDRL | HAE |
|---|---|---|
| Price | $48.38 | $54.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $56.00 | ★ $84.13 |
| AVG Volume (30 Days) | 503.0K | ★ 631.0K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.61 | 44.54 |
| EPS | N/A | ★ 2.46 |
| Revenue | ★ $1,437,000,000.00 | $910,373,000.00 |
| Revenue This Year | $5.22 | N/A |
| Revenue Next Year | $16.68 | $5.23 |
| P/E Ratio | ★ N/A | $22.17 |
| Revenue Growth | ★ 3.75 | N/A |
| 52 Week Low | $22.30 | $47.32 |
| 52 Week High | $50.24 | $87.32 |
| Indicator | SDRL | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 55.70 | 42.10 |
| Support Level | $28.68 | $54.92 |
| Resistance Level | $49.61 | $56.64 |
| Average True Range (ATR) | 1.23 | 2.73 |
| MACD | -0.18 | -0.60 |
| Stochastic Oscillator | 54.90 | 41.01 |
Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, and others. The company derives maximum revenue from Brazil.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.